menu search

Better buy: take-two interactive vs. electronic arts stock

Both developers have huge content portfolios. Take-Two isn't profitable today but is targeting much fas...

July 12, 2023, 5:42 am

Qqew: special rebalancing may spur outperformance against qqq

First Trust NASDAQ-100 Equal Weighted Index Fund invests in the Nasdaq 100 Index in an equal-weighted manner. The Nasdaq 100 Index's 'Special Rebalanc...

July 12, 2023, 4:29 am

Troilus gold says additional assays continue to highlight high-grade trends of zone x22

Troilus Gold Corp (TSX:TLG, OTCQX:CHXMF) has reported additional assay results from Zone X22 at the gold-copper Troilus Project, located in northcent...

July 11, 2023, 8:17 am

Microsoft is cutting more jobs, after laying off 10,000 earlier this year

GeekWire first reported that a new round of cuts was announced Monday, targeting employees in customer ...

July 10, 2023, 9:30 pm

Viking therapeutics (vktx) surges 64% year to date: here's why

The rising share price of Viking Therapeutics (VKTX) is attributable to the successful development of the company's pipeline candidates,...

July 10, 2023, 11:00 am

Is it too late to buy palo alto networks?

Cybersecurity is proving to be a resilient industry. Palo Alto Networks is targeting positive earnings ...

July 6, 2023, 6:58 am

Correlate infrastructure partners and edge renewable partners launch joint venture targeting $100m initial capital deployment to accelerate microgrid development

BOISE, Idaho, July 05, 2023 (GLOBE NEWSWIRE) — Correlate Infrastructure Partners Inc. (OTCQB: CIPI) is excited to announce that it has entered into ...

July 5, 2023, 8:30 pm

C4 therapeutics announces fda clearance of investigational new drug application for cft8919, an orally bioavailable bidac™ degrader targeting egfr l858r for non-small cell lung cancer

WATERTOWN, Mass., July 05, 2023 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated ...

July 5, 2023, 11:00 am

Evotec wins orthopoxvirus antibody contract from u.s. government

Evotec's Seattle-based subsidiary has won a $74 million contract with the U.S. Department of Defence to develop monoclonal antibody-based drugs...

July 5, 2023, 1:59 am

China's former vice commerce minister says china's export control measures just a start

China's former vice Commerce Minister says China's export control measures of chipmaking materials is just a start.China has further sanctions tools, ...

July 5, 2023, 1:53 am

Usd/cad justifies bearish bias targeting 1.3200 amid downbeat options market signals

AUD/USD justifies risk-barometer status as it pauses the four-day winning streak while making rounds to 0.6690 amid the early hours of Wednesday’s A...

July 5, 2023, 1:29 am

Cggr: banner 2023 amid growth rotation, issues under the hood

CGGR is a relatively novel investment vehicle targeting U.S. large and mid caps that "appear to offer s...

July 3, 2023, 9:37 pm

Casey's (casy) sets ambitious three-year strategic plan

Casey's (CASY) newly unveiled strategic plan reflects the company's commitment to sustainable growth, targetin...

July 3, 2023, 12:12 pm

Analysts are raising expectations for these 3 auto stocks

Targeting areas of the market that are seeing positive earnings estimate revisions is an excellent way for investors to insert themselves in favorable...

June 30, 2023, 6:57 pm

Sage therapeutics: zuranolone august approval likely, opportunity uncertain

Sage Therapeutics, Inc. should find out in August whether its drug targeting major depressive disorder ...

June 30, 2023, 1:15 pm

Ftc reportedly plans lawsuit against amazon over merchant pricing

The Federal Trade Commission is planning to file another lawsuit against Amazon targeting its online ma...

June 30, 2023, 12:15 pm

Is etsy stock a buy? 3 things investors should know

Sales volume trends haven't impressed investors over the last few quarters. Still, the e-commerce site is targ...

June 29, 2023, 11:30 am

Gbp/usd analysis: decline targeting 1.2544 daily support [video]

AUD/USD rebounds swiftly from a multi-month low, albeit the upside potential seems limited. A positive risk tone keeps the USD bulls on the defensive ...

June 29, 2023, 2:59 am

Molecular partners to present on its radio darpin therapy (rdt) platform at snmmi 2023

RDT platform offers unique approach for tailored delivery of radioactive payloads to solid tumors RDT platform is focused on improving both tumor-targ...

June 27, 2023, 5:00 am

Molecular partners to present on its radio darpin therapy (rdt) platform at snmmi 2023

RDT platform offers unique approach for tailored delivery of radioactive payloads to solid tumors RDT platform is focused on improving both tumor-targ...

June 27, 2023, 1:00 am


Search within

Pages Search Results: